Subcutaneous delivery of insulin loaded poly(fumaric-co-sebacic anhydride) microspheres to type 1 diabetic rats

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 63, Issue 2, 2006, Pages 229-236

  Furtado, Stacia ^a   Abramson, Danielle ^a   Simhkay, Liat ^a   Wobbekind, Daniel ^a   Mathiowitz, Edith ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Diabetic rat; Insulin; Microspheres; Poly(fumaric co sebacic anhydride); Subcutaneous delivery

Indexed keywords

INSULIN; MICROSPHERE; NANOPARTICLE; POLY(FUMARIC CO SEBACIC ANHYDRIDE); UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STABILITY; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROENCAPSULATION; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; RAT;

ANHYDRIDES; ANIMALS; BIOLOGICAL AVAILABILITY; BLOOD GLUCOSE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DECANOIC ACIDS; DIABETES MELLITUS, TYPE 1; FUMARATES; INJECTIONS, SUBCUTANEOUS; INSULIN; MICROSCOPY, ELECTRON, SCANNING; POLYMERS; RATS;

EID: 33646823305     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2005.12.012     Document Type: Article

References (19)

1. Craig C.R., and Stitzel R.E. Modern Pharmacology (1986), Little, Brown and Company, Boston
2. Takenaga M.Y., Kitagawa Y., Ogawa A., Kawai Y., Mizushima S., and Igarashi Y.R. Optimum formulation for sustained-release insulin. International Journal of Pharmaceutics 271 (2004) 85-94
3. Caliceti P., Veronese F.M., and Lora S. Polyphosphazene microspheres for insulin delivery. International Journal of Pharmaceutics 211 (2000) 57-65
4. Caliceti P., Salmaso S., Lante A., Yoshida M., Katakai R., Martellini F., Mei L.H.I., and Carenza M. Controlled release of biomolecules from temperature-sensitive hydrogels prepared by radiation polymerization. Journal of Controlled Release 75 (2001) 173-181
5. Reithmeier H., Herrmann H., and Gopferich A. Lipid microparticles as a parenteral controlled release device for peptides. Journal of Controlled Release 73 (2001) 339-350
6. Leoni L., and Desai T.A. Nanoporous biocapsules for the encapsulation of insulinoma cells: biotransport and biocompatibility. IEEE Transactions on Biomedical Engineering 48 (2001) 1335-1341
7. Carino G.P., Jacobs J.S., and Mathiowitz E. Nanosphere based oral insulin delivery. Journal of Controlled Release 65 1-2 (2000) 261-269
8. Leong K.W., Kost J., Mathiowitz E., and Langer R. Polyanhydrides for controlled release of bioactive agents. Biomaterials 7 (1986) 364-371
9. Guberski D.L. Diabetes-prone and diabetes-resistant BB rats: animal models of spontaneous and virally induced diabetes mellitus, lymphocytic thyroiditis, and collagen-induced arthritis. ILAR News 35 (1994) 29-36
10. Yagihashi S., and Sima A. Diabetic autonomic neuropathy in the BB rat. Ultrastructural and morphometric changes in sympathetic nerves. Diabetes 34 (1985) 558-564
11. Oliva A., Fariña J., and Llsbrés M. Development of two high-performance liquid chromatographic methods for the analysis and characterization of insulin and its degradation products in pharmaceutical preparations. Journal of Chromatography B 749 (2000) 25-34
12. PharmaEuropa, 8 (1996), pp. 359-360.
13. Dhanesar S.C., DePalma P., Kader A., SZhao Z., Dordunoo S., and Dang W. Quantitation of insulin released from polyphosphoester microspheres. International Symposium Controlled Release of Bioactive Materials (2000)
14. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., and Klenk D.C. Measurement of protein using bicinchoninic acid. Analytical Biochemistry 150 (1985) 76-85
15. Wiechelman K., Braun R., and Fitzpatrick J. Investigation of the bicinchoninic acid protein assay: identification of the groups responsible for color formation. Analytical Biochemistry 175 (1988) 231-237
16. Hwang D.L., Barseghian G., and Lev-Ran A. Determination of free-insulin in antibody containing sera: comparison of polyethylene glycol and Staphylococcus aureus cells. Hormone and Metabolic Research 17 (1985) 595-597
17. Jacobs J., and Mathiowitz E. A novel mechanism for spontaneous encapsulation of active agents: phase inversion nanoencapsulation. In: Svensonin S. (Ed). Carrier-Based Drug Delivery (2004), American Chemical Society, Washington, DC 214-223
18. Yomota C., Yoshii Y., Takahata T., and Okada S. Separation of B-3 monodesamidoinsulin from human insulin by high-performance liquid chromatography under alkaline conditions. Journal of Chromatography A 721 (1996) 89-96
19. Chetty D.J., and Chen Y.W. Novel methods of insulin delivery: an update. Critical Reviews in Therapeutic Drug Carrier Systems 15 (1998) 629-670